BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15017692)

  • 1. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
    Leng WD; Wang DZ; Feng G; He J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of multiple drug resistance associated genes in ovarian cancer].
    Cheng G; Zhu H; Sun L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].
    Cao DY; Shen K; Yang JX; Guan J
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):304-7. PubMed ID: 11778556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of glutathione S-transferase, P-glycoprotein, and multidrug resistance-associated protein in neuroblastoma and its clinical significance].
    Lü Q; Li X; Zhang J; Ma Y; Wang X; Jiang W
    Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):506-9. PubMed ID: 12622900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance].
    Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significance].
    Huang BT; Xiao Z; Shi YT; Ha S; Zhao WH; Gao D; Yan XH; Yang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):262-6. PubMed ID: 17493328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
    Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
    J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of the expression of MDR genes and MDR genes-coded product with prognosis in laryngopharyngeal malignant melanoma].
    Chen X; Ji T; Yao L; Yang J; Deng J; Zhang Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Sep; 16(9):459-61. PubMed ID: 15515530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers.
    Kim WJ; Kakehi Y; Wu WJ; Fukumoto M; Yoshida O
    Br J Urol; 1996 Sep; 78(3):361-8. PubMed ID: 8881943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].
    Yu PF; Guo JM; Xu Q; Ying JE; Wang XJ; Cheng XD; Wang XB; Yu CD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):289-93. PubMed ID: 20422488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance.
    Xiang F; Yu W; Shen Y; Wu C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):398-405. PubMed ID: 21126409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.